Načítá se...
干扰素α-1b、白细胞介素2联合沙利度胺方案干预治疗微小残留病阳性急性髓系白血病的疗效分析
OBJECTIVE: To explore the effect of combination regimen of interferon alpha-1b, interleukin-2 and thalidomide (ITI regimen) on minimal residual disease (MRD) in patients with acute myeloid leukemia (AML) who were in hematologic remission but MRD-positive. METHODS: Eighteen patients (17 from Tumor Ho...
Uloženo v:
| Vydáno v: | Zhonghua Xue Ye Xue Za Zhi |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Editorial office of Chinese Journal of Hematology
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7342653/ https://ncbi.nlm.nih.gov/pubmed/30831625 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.02.004 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|